This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Document and Entity Information
Financial Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive Loss
Consolidated Statements of Operations and Comprehensive Loss (Parenthetical)
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit)
Consolidated Statements of Cash Flows
Notes to Financial Statements
Organization and Basis of Presentation
Significant Accounting Policies
Investments
Fair Value Measurements
Property and Equipment, Net
Accrued Expenses
Acquisition with Epiva Biosciences, Inc. (Epiva)
Loan and Security Agreement
In-License Agreements
Commitments and Contingencies
Stockholders’ Equity (Deficit) and Convertible Preferred Stock
Stock-Based Compensation
Income Taxes
Net Loss Per Share
Related Party Transactions
Selected Quarterly Financial Information
Accounting Policies
Significant Accounting Policies (Policies)
Notes Tables
Significant Accounting Policies (Tables)
Investments (Tables)
Fair Value Measurements (Tables)
Property and Equipment, Net (Tables)
Accrued Expenses (Tables)
Acquisition with Epiva Biosciences, Inc. (Epiva) (Tables)
Loan and Security Agreement (Tables)
Commitments and Contingencies (Tables)
Stock-Based Compensation (Tables)
Income Taxes (Tables)
Net Loss Per Share (Tables)
Selected Quarterly Financial Information (Tables)
Notes Details
Organization and Basis of Presentation - Narrative (Details)
Significant Accounting Policies - Narrative (Details)
Significant Accounting Policies - Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)
Significant Accounting Policies - Estimated Useful Lives of Property and Equipment (Details)
Investments - Narrative (Details)
Investments - Summary of Investments Classified as Available-For-Sale (Details)
Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value (Details)
Fair Value Measurements - Narrative (Details)
Fair Value Measurements - Summary of Assumptions in Valuing Material Warrants (Details)
Fair Value Measurements - Roll-Forward of Fair Value of Warrant And Debt Derivative Liability Measured at Fair Value on a Recurring Basis (Details)
Property and Equipment, Net - Summary of Property and Equipment (Details)
Property and Equipment, Net - Narrative (Details)
Accrued Expenses (Details)
Acquisition with Epiva Biosciences, Inc. (Epiva) - Narrative (Details)
Acquisition with Epiva Biosciences, Inc. (Epiva) - Schedule of Asset Acquisition (Details)
Loan and Security Agreement - Narrative (Details)
Loan and Security Agreement - Schedule of Minimum Aggregate Future Loan Payments (Details)
In-License Agreements - Narrative (Details)
Commitments and Contingencies - Narrative (Details)
Commitments and Contingencies - Schedule of Minimum Aggregate Future Lease Commitments (Details)
Stockholders’ Equity (Deficit) and Convertible Preferred Stock - Narrative (Details)
Stock-Based Compensation - Narrative (Details)
Stock-Based Compensation - Summary of Stock-based Compensation Expense (Details)
Stock-Based Compensation - Summary of Stock Option Activity (Details)
Stock-Based Compensation - Schedule of Stock Option Valuation Assumptions (Details)
Stock-Based Compensation - Summary of Restricted Stock Activity (Details)
Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)
Income Taxes - Schedule of Deferred Tax Assets (Details)
Income Taxes - Narrative (Details)
Net Loss Per Share - Summary of Potentially Dilutive Securities Excluded from Computation of Diluted Weighted-Average Shares Outstanding (Details)
Related Party Transactions - Narrative (Details)
Selected Quarterly Financial Information (Details)
All Reports
Rendering Log